ArticleCancer research and treatment2015

Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis.

Junshik Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.